Study links obesity to liver failure

May 24, 2006

LOS ANGELES (May 24, 2006) - Researchers have found that obesity can put patients with acute liver failure at increased risk of mortality and other major complications, according to a new study presented today at Digestive Disease Week® 2006 (DDW). DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

The connection between diabetes and obesity in the development of non-alcoholic fatty liver disease (NAFLD) has been well established; however, little is known about the possible link between these factors and acute liver failure (ALF). Investigators from Massachusetts General Hospital and the National Institutes of Health-funded Acute Liver Failure Study Group researched this connection and found that although obesity does not appear more prevalent in ALF cases, patients who are obese or morbidly obese have significantly poorer outcomes with ALF. ALF is a serious medical condition in which large portions of the liver quickly become so damaged that the liver is no longer able to function, putting patients at risk of severe complications and death.

Study authors examined 572 patients suffering from ALF and documented body mass index (BMI), prevalence of diabetes and patient outcome. The number of obese patients in the study was consistent with the prevalence of obesity in the general U.S. population. However, the mean BMI score was higher (28.8 versus 26.6) for ALF patients who needed liver transplants or died. In addition, obese ALF patients were almost twice as likely to need a transplant or die as non-obese patients. Finally, obese patients were also more than three times more likely to die post-liver transplant than non-obese patients. Because many of these obese patients have NAFLD, which has been shown to impair liver regeneration, they may have less capacity to regenerate or recover from acute liver failure than their non-obese counterparts.

"While obesity may not be a risk factor for the development of ALF, obese ALF patients are at serious risk of major liver-related complications and death," said Anna Rutherford, M.D., Massachusetts General Hospital and lead study author. "Physicians should encourage patients to maintain a healthy weight to help improve their health and outcome."
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 20-25, 2006 in Los Angeles, California. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology.

American Gastroenterological Association

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to